| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.10B | +210.5% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | — |
| Gross margin | 23.5% | Net margin -5.5% |
| Revenue Q/Q | -31.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.08B | 76.5% |
| R&D | ¥0.01B | 5.7% |
| SG&A | ¥0.02B | 22.9% |
| Tax & other | ¥0.00B | 0.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
蒙泰高新 ・ 金春股份 ・ 维康药业 ・ 大叶股份 ・ 迦南智能 ・ 盛德鑫泰 ・ 万胜智能 ・ 龙利得 ・ 狄耐克 ・ 海昌新材 ・ 华业香料 ・ 谱尼测试
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies